Shares of Versigent (NYSE:VGNT – Get Free Report) have received an average recommendation of “Buy” from the eleven ratings firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $47.3333.
Several research firms have recently commented on VGNT. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $38.00 target price on shares of Versigent in a research report on Thursday, May 7th. Evercore reaffirmed an “outperform” rating and issued a $60.00 target price on shares of Versigent in a report on Monday, May 18th. TD Cowen raised their price target on Versigent from $47.00 to $49.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Royal Bank Of Canada started coverage on Versigent in a research note on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 price objective on the stock. Finally, Wells Fargo & Company increased their target price on Versigent from $42.00 to $48.00 and gave the company an “overweight” rating in a research report on Thursday, June 25th.
View Our Latest Analysis on Versigent
Versigent Stock Down 6.1%
Featured Articles
- Five stocks we like better than Versigent
- Top 135 Best Locally Owned BBQ Supply Stores in the U.S., According to Survey [2026]
- Silicon Starvation: Amazon Feasts on Legacy GPUs
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
- Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
